EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Novel Aspects of the Immune Response Involved in the Peritoneal Damage in Chronic Kidney Disease Patients under Dialysis

Flavia Trionfetti iD, Vanessa Marchant iD, Guadalupe T González-Mateo iD, Edyta Kawka iD, Laura Márquez-Expósito iD, Alberto Ortiz iD, Manuel López-Cabrera iD, Marta Ruiz-Ortega iD, Raffaele Strippoli iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24065763 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Flavia Trionfetti und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy. Hauptthemen laut MEDLINE: COVID-19, Peritonitis, Renal Insufficiency, Chronic, Kidney Failure, Chronic. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 245 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Instituto de Salud Carlos III (ISCIII) and Fondos FEDER European Union, Red de Investigación Renal REDINREN.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease (CKD) incidence is growing worldwide, with a significant percentage of CKD patients reaching end-stage renal disease (ESRD) and requiring kidney replacement therapies (KRT). Peritoneal dialysis (PD) is a convenient KRT presenting benefices as home therapy. In PD patients, the peritoneum is chronically exposed to PD fluids containing supraphysiologic concentrations of glucose or other osmotic agents, leading to the activation of cellular and molecular processes of damage, including inflammation and fibrosis. Importantly, peritonitis episodes enhance peritoneum inflammation status and accelerate peritoneal injury. Here, we review the role of immune cells in the damage of the peritoneal membrane (PM) by repeated exposure to PD fluids during KRT as well as by bacterial or viral infections. We also discuss the anti-inflammatory properties of current clinical treatments of CKD patients in KRT and their potential effect on preserving PM integrity. Finally, given the current importance of coronavirus disease 2019 (COVID-19) disease, we also analyze here the implications of this disease in CKD and KRT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19PeritonitisRenal Insufficiency, ChronicKidney Failure, ChronicHumansPeritoneumRenal DialysisDialysis SolutionsInflammationImmunity

Stichwörter der Autor:innen

COVID-19immune systeminflammationkidneyperitoneal dialysisperitoneal fibrosis

Substanzen

Dialysis Solutions

Autor:innen und Institutionen

  • Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy.
  • Department of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases L., Spallanzani, IRCCS, Via Portuense, 292, 00149 Rome, Italy.
  • Cellular Biology in Renal Diseases Laboratory, IIS-Fundación Jiménez Díaz-Universidad Autónoma Madrid, 28040 Madrid, Spain.
  • REDINREN/RICORS2040, 28029 Madrid, Spain.
  • Cell-Cell Communication & Inflammation Unit, Centre for Molecular Biology "Severo Ochoa" (CSIC-UAM), 28049 Madrid, Spain.
  • Premium Research, S.L., 19005 Guadalajara, Spain.

ORCID-Profile: Flavia Trionfetti, Vanessa Marchant, Guadalupe T González-Mateo, Edyta Kawka, Laura Márquez-Expósito, Alberto Ortiz, Manuel López-Cabrera, Marta Ruiz-Ortega, Raffaele Strippoli

Förderung

  • Instituto de Salud Carlos III
  • Instituto de Salud Carlos III (ISCIII) and Fondos FEDER European Union
  • Red de Investigación Renal REDINREN
  • European Union—NextGenerationEU, Sociedad Española de Nefrología
  • European Union’s Horizon 2020
  • Narodowe Centrum Nauki
  • Ministry for Health of Italy (Ricerca Corrente)
  • Spanish Ministry of Science and Innovation/Fondo Europeo de Desarrollo Regional (MICINN/FEDER)

Zitieren

APA

Trionfetti, F., Marchant, V., González-Mateo, G. T., Kawka, E., Márquez-Expósito, L., Ortiz, A., López-Cabrera, M., Ruiz-Ortega, M., & Strippoli, R. (2023). Novel Aspects of the Immune Response Involved in the Peritoneal Damage in Chronic Kidney Disease Patients under Dialysis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065763

Vancouver

Trionfetti F, Marchant V, González-Mateo GT, Kawka E, Márquez-Expósito L, Ortiz A, et al. Novel Aspects of the Immune Response Involved in the Peritoneal Damage in Chronic Kidney Disease Patients under Dialysis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24065763

BibTeX
@article{Trionfetti2023,
  author = {Trionfetti, Flavia and Marchant, Vanessa and González-Mateo, Guadalupe T and Kawka, Edyta and Márquez-Expósito, Laura and Ortiz, Alberto and López-Cabrera, Manuel and Ruiz-Ortega, Marta and Strippoli, Raffaele},
  title = {Novel Aspects of the Immune Response Involved in the Peritoneal Damage in Chronic Kidney Disease Patients under Dialysis},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24065763}
}
Kostenlos starten →